Bristol Myers Squibb to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
04 Juin 2024 - 12:59PM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will participate in the Goldman Sachs 45th Annual Global
Healthcare Conference.
Christopher Boerner, Ph.D., Board Chair and Chief Executive
Officer, will take part in a fireside chat on Tuesday, June 11,
2024. He will answer questions about the company beginning at 11:20
a.m. ET.
Investors and the general public are invited to listen to a live
webcast of the session by visiting http://investor.bms.com. An
archived edition of the session will be available following its
conclusion.
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop, and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240604456010/en/
Media: media@bms.com Investors:
investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Bristol Myers Squibb (NYSE:BMY)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
